Evaluation of inflammatory and biochemical markers in COVID-19 patients treated with tocilizumab alone or with the combination of tocilizumab and convalescent plasma transfusion. Annals of Medical Research, [S. l.], v. 29, n. 7, p. 770–776, 2022. Disponível em: http://annalsmedres.org/index.php/aomr/article/view/4231. Acesso em: 4 apr. 2025.